QIAGEN Introduces QIAsymphony Sample Processing Option to GeneReader NGS Workflow for Non U.S. Customers

HILDEN, Germany, October 5, 2016 /PRNewswire/ --

QIAsymphony SP front-end adds higher sample throughput and additional flexibility to GeneReader NGS System

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the launch outside of the United States of its QIAsymphony SP instrument as a front-end option for sample processing for the GeneReader NGS System*, adding highly automated, higher throughput sample volumes and high flexibility to the world's first complete Sample to Insight solution for next-generation sequencing (NGS). The GeneReader NGS workflow can now integrate seamlessly with QIAsymphony SP, enabling laboratories outside the United States to perform sample processing of different sample types simultaneously with continuous loading, random access and greater speed for demanding environments.

"Where available, the GeneReader NGS System is gaining adoption as a complete, user-friendly solution for next-generation sequencing, and QIAsymphony SP adds a reliable front-end to the GeneReader NGS System for higher throughput workflows. We are currently marketing the GeneReader NGS workflow outside the United States. As an alternative to the QIAcube, which automates lower throughput sample processing, QIAsymphony SP handles varying sample volumes and types simply and efficiently for GeneReader NGS users," said Jonathan Arnold, QIAGEN's Oncology Franchise Business Leader.

Click here for full press release

https://www.qiagen.com/about-us/press-releases/pressreleaseview?ID={AB23227B-C4EC-4081-96A5-C5F5D2E61269}&lang=en

Contacts:

Public Relations:
Dr. Thomas Theuringer
Senior Director Public Relations
[phone]

Email: [e-mail]
http://www.twitter.com/qiagen
https://www.facebook.com/QIAGEN
pr.qiagen.com

Investor Relations:
John Gilardi
Vice President Corporate Communications and Investor Relations
[phone]

Email: [e-mail]
ir.qiagen.com